Clinical trial
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis…
NCT00303485 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00303485 |
|---|---|
| Title | A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) |
| Official title | A Randomized, Double-blind, Placebo-controlled Study to Determine Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once Monthly Ibandronate in the Treatment of Postmenopausal Osteoporosis |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post Menopausal Osteoporosis |
| Intervention type | Drug |
| Interventions | Placebo, Vitamin D and calcium supplementation, ibandronate [Bonviva/Boniva] |
| Enrollment | 67 |
| Start date | Feb 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Mar 17, 2006 |
| Last update posted | May 2, 2016 |
| Countries | Puerto Rico, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: